This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit June 04, 2014

Home   About   Membership   Awards   Knowledge Center   Divisions   Advocacy   Career Center        


 


ASPET NEWS


Submit a Proposal for the ASPET Big Ideas Initiative!
ASPET
The ASPET Council is inviting members to bring forward their BIG IDEAS for ASPET projects. Members can propose a new ASPET award, an idea to help train our student members, or a project from your division's action plan that will directly benefit ASPET members. This is your opportunity to put your BIG IDEAS forward!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New ASPET Award: The David Lehr Research Award
ASPET
ASPET is pleased to announce a new society award, the David Lehr Research Award. This award is made possible by an endowment to ASPET from Mrs. Lisa Lehr in honor of her husband, the late Dr. David Lehr, former chair of the Department of Pharmacology for New York Medical College. The award is intended to extend funding for preclinical or clinical research directed towards improving human health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Call for 2015 Award Nominations
ASPET
ASPET presents several major awards to recognize accomplishments either in specific areas of pharmacology or contributions to and accomplishments in the discipline in general. The award nominations for 2015 are now open! Send us your nominations by September 15, 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ASPET Member in the News: Dr. Beth Habecker
ASPET
Beth Habecker, PhD, has accepted the position of interim chair of the Department of Physiology and Pharmacology at the Oregon Health & Science University. She will formally assume the role after the current chair David Dawson, PhD, steps down on July 1, 2014.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
CLICK HERE


Early Career Reviewer Program
ASPET
Thinking about becoming an Early Career Reviewer? The NIH Center for Scientific Review (CSR) Early Career Reviewer (ECR) program was developed to train qualified scientists without prior CSR review experience to become effective reviewers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Support the John J. Abel Award in Pharmacology by Donating to the John J. Abel Award Endowment Fund
ASPET
The Abel Award recognizes young scientists who are doing fundamental research in pharmacology and experimental therapeutics. Help us reach our goal of raising $200K by taking the time now to make your tax-deductible donation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SCIENCE POLICY NEWS


ASPET Urges Congressional Appropriators to Make NIH Funding a National Priority
ASPET
Noting that the FY 2015 Labor/HHS, Education & Related Agencies Appropriations Subcommittee allocation that funds NIH is 12% below FY 2010, ASPET's leadership wrote to the Senate Appropriations leadership expressing concern over funding constraints imposed by existing discretionary budget caps.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


House Provides FDA with Minimal Increase
ASPET
The House Appropriations Committee recently approved the FY 2015 funding level for the Food and Drug Administration. At $2.583 billion, the agency's budget increases by $23 million but leaves it with less than 1% increase above the FY 2014 level.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Grad Students and Post Docs: Applications are Open for 2015 ASPET Washington Fellows Program
ASPET
The ASPET Washington Fellows Program enables developing and early career scientists interested in science policy to become more engaged in public policy issues. Fellows will develop an understanding of how public policy decisions made in Washington help shape and impact science policy, such as funding for the National Institutes of Health and other science agencies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


OTHER NEWS


Jobs Available!
ASPET
ASPET's Career Center resources help you look for jobs in your area of specialty and proactively manage your career goals. Learn more about our newest listings!

Postdoctoral Fellow - UT Health Science Center at San Antonio, San Antonio, TX

Postdoctoral Fellow in Pharmacology/Toxicology - Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Jefferson, AR

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Useful Links
ASPET
EB 2014 Abstracts Available Online in The FASEB Journal
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


ASPET ANNUAL MEETING AT EB 2015 NEWS


Important Dates for EB 2015 are Now Available!
ASPET
Our next annual meeting will be held in Boston from March 28–April 1 next year. Information on important dates and registration rates for EB 2015 is now available on the EB 2015 website. Be sure to save the date!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
CLICK HERE


NEWS FROM THE FIELD


New gene responsible for rare brain cancer found
Medical Daily
Researchers have achieved a breakthrough while studying the possible genetic causes of brainstem glioma, a rare and potentially deadly cancer of the brain, which is mostly diagnosed in children and young adults. This discovery may aid in the development of therapeutic options to treat this cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Analysis suggests drug combination may effectively treat ovarian cancer
National Institutes of Health
Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology meeting in Chicago. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The drugs were tested in a phase I combination study followed by a randomized phase 2 trial sponsored by the National Cancer Institute.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Alzheimer's disease and other conditions linked to prion-like proteins
Neuroscience News
A new theory about disorders that attack the brain and spinal column has received a significant boost from scientists at Washington University School of Medicine in St. Louis. The theory attributes these disorders to proteins that act like prions, which are copies of a normal protein that have been corrupted in ways that cause diseases.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASPET News Brief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin Harrison, MultiView Content Editor, 469.420.2657  
Contact MultiView


Prateeksha Nagar, ASPET Contact, 301.634.7916
Contact ASPET


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the ASPET News Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

May 14, 2014
May 14, 2014
April 16, 2014
April 2, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063